Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ATEC
Upturn stock ratingUpturn stock rating

Alphatec Holdings Inc (ATEC)

Upturn stock ratingUpturn stock rating
$10.94
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/20/2025: ATEC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

10 Analysts rated it

Well-followed company, solid analyst reports, reliable data for confident investing.

1 Year Target Price $18.32

1 Year Target Price $18.32

Analysts Price Target For last 52 week
$18.32Target price
Low$4.88
Current$10.94
high$13.13

Analysis of Past Performance

Type Stock
Historic Profit 8.12%
Avg. Invested days 35
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 2.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.62B USD
Price to earnings Ratio -
1Y Target Price 18.32
Price to earnings Ratio -
1Y Target Price 18.32
Volume (30-day avg) 10
Beta 1.11
52 Weeks Range 4.88 - 13.13
Updated Date 06/30/2025
52 Weeks Range 4.88 - 13.13
Updated Date 06/30/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.14

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -25.77%
Operating Margin (TTM) -18.74%

Management Effectiveness

Return on Assets (TTM) -9.33%
Return on Equity (TTM) -291.71%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 2044701095
Price to Sales(TTM) 2.53
Enterprise Value 2044701095
Price to Sales(TTM) 2.53
Enterprise Value to Revenue 3.18
Enterprise Value to EBITDA -18.89
Shares Outstanding 146172992
Shares Floating 114153572
Shares Outstanding 146172992
Shares Floating 114153572
Percent Insiders 21.48
Percent Institutions 63.44

Analyst Ratings

Rating 4
Target Price 18.32
Buy 5
Strong Buy 4
Buy 5
Strong Buy 4
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Alphatec Holdings Inc

stock logo

Company Overview

overview logo History and Background

Alphatec Holdings, Inc. (ATEC) was founded in 2006. It has grown through acquisitions and internal development to become a significant player in the spinal surgery market.

business area logo Core Business Areas

  • Spinal Implants: Designs, develops, and markets a range of spinal implants used in surgical procedures to treat spinal disorders.
  • Biologics: Offers biologic products used to promote spinal fusion and healing.
  • Surgical Access Systems: Provides access systems that facilitate minimally invasive spinal surgery.
  • Navigation: Offers a navigation and imaging system to improve surgical accuracy.

leadership logo Leadership and Structure

ATEC is led by Patrick S. Miles, Chairman and CEO. The company has a typical corporate structure with executive leadership overseeing various departments such as sales, marketing, research and development, and operations.

Top Products and Market Share

overview logo Key Offerings

  • EOS imaging platform: EOS imaging platform is used for 2D and 3D orthopedic imaging. This generated estimated revenue of $21 million (FY2023). Competitors include Siemens Healthineers, GE Healthcare, and Canon Medical.
  • Invictus Spinal Fixation System: Invictus Spinal Fixation System is a posterior fixation system used in spinal surgeries. Market share data is not readily available. Competitors include Medtronic's CD HORIZON, DePuy Synthes' VIPER and NuVasive's RELINE systems.
  • SafeOp Neural Monitoring System: The SafeOp Neural Monitoring System helps surgeons avoid nerve damage during procedures. Competitors include Medtronic's NIM-ECLIPSE, and NuVasive's Pulse platform

Market Dynamics

industry overview logo Industry Overview

The spinal device market is characterized by technological innovation, an aging population, and increasing prevalence of spinal disorders. It's a competitive market with both large established players and smaller, innovative companies.

Positioning

ATEC is positioned as a growth-oriented company focused on innovation and expanding its market share in the spinal device market. Their competitive advantage relies on product innovation like the EOS imaging and SafeOp systems as well as their focus on AlphaInformatiX platform.

Total Addressable Market (TAM)

The global spine market is estimated at $10-12 billion. ATEC is targeting a larger share of this market through product innovation and strategic acquisitions.

Upturn SWOT Analysis

Strengths

  • Innovative product portfolio
  • Strong growth in revenue
  • Strategic acquisitions to expand capabilities
  • Proprietary technology such as SafeOp
  • Focus on data analytics

Weaknesses

  • Relatively small market share compared to larger competitors
  • History of net losses
  • High operating expenses
  • Reliance on key personnel

Opportunities

  • Increasing adoption of minimally invasive surgery
  • Aging population and rising incidence of spinal disorders
  • Expansion into new geographic markets
  • Development of new technologies and products
  • Further acquisitions to expand product lines

Threats

  • Intense competition from established players
  • Pricing pressures from healthcare providers
  • Regulatory hurdles for new products
  • Product liability claims
  • Economic downturns impacting healthcare spending

Competitors and Market Share

competitor logo Key Competitors

  • Medtronic (MDT)
  • Stryker (SYK)
  • Johnson & Johnson (JNJ)
  • Globus Medical (GMED)
  • NuVasive (GNTX)

Competitive Landscape

Alphatec is a smaller player competing with larger, more established companies. Its competitive advantage lies in its innovative products, technology and a focused approach.

Major Acquisitions

EOS imaging

  • Year: 2020
  • Acquisition Price (USD millions): 119.6
  • Strategic Rationale: Extended ATEC's portfolio into advanced orthopedic imaging.

Growth Trajectory and Initiatives

Historical Growth: Alphatec has demonstrated strong revenue growth in recent years, driven by product innovation and strategic acquisitions.

Future Projections: Analyst projections estimate continued revenue growth, with a path towards profitability.

Recent Initiatives: Recent initiatives include launching new products, expanding sales force, and acquiring complementary businesses.

Summary

Alphatec is a growth-oriented spinal device company with innovative products and a strategic focus. While they are up against much larger competitors, their strong revenue growth and unique technology, like the SafeOp system, position them well. However, consistent profitability remains a challenge, and they must carefully manage operating expenses and regulatory hurdles to thrive. Expansion into new markets and further innovation will be critical for long-term success.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Alphatec Holdings Inc. Investor Relations
  • SEC Filings (10-K, 10-Q)
  • Industry Reports
  • Analyst Estimates
  • Company press releases

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Market data and estimates are subject to change. Investors should conduct their own research before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Alphatec Holdings Inc

Exchange NASDAQ
Headquaters Carlsbad, CA, United States
IPO Launch date 2006-06-02
Executive Chairman, CEO & President Mr. Patrick S. Miles
Sector Healthcare
Industry Medical Devices
Full time employees 867
Full time employees 867

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.